A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
NCT07520747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000
Last updated 2026-05-08
Summary
The purpose of this study is:
* to find out out the number of children who develop crohn's disease (CD) and ulcerative colitis (UC) each year and are living with the disease and to see how this differs by age groups.
* to understand how children of different age groups are treated over time and how their treatment changes as they grow.
* to assess how often children use healthcare services and how much this costs for different age groups over several years.
CD and UC are long-term diseases that cause inflammation in intestine (part of digestive system) and develop ulcers.
Conditions
- Inflammatory Bowel Diseases
Sponsors & Collaborators
-
Janssen Korea, Ltd., Korea
lead INDUSTRY
Principal Investigators
-
Janssen Korea, Ltd. Clinical Trial · Janssen Korea, Ltd.
Eligibility
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-07
- Primary Completion
- 2026-06-20
- Completion
- 2026-06-29
Countries
- South Korea
Study Locations
More Related Trials
-
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.
NCT01731665 ·Status: RECRUITING
-
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
NCT02799615 ·Status: COMPLETED
-
The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases
NCT03640637 ·Status: UNKNOWN
-
Pediatric Penetrating Crohn's Disease
NCT04119635 ·Status: COMPLETED
-
Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis
NCT06922331 ·Status: COMPLETED
-
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
NCT05321758 ·Status: RECRUITING ·Phase: NA
-
Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease
NCT02319798 ·Status: COMPLETED ·Phase: NA
-
Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis
NCT02579733 ·Status: TERMINATED ·Phase: PHASE4
-
Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD)
NCT04887428 ·Status: COMPLETED
-
Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease
NCT03026582 ·Status: COMPLETED
-
Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients
NCT04660136 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Intestinal Inflammation by Infrared Thermography in Pediatric Crohn Disease
NCT05710276 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
NCT00606346 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease
NCT00207675 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease
NCT01671579 ·Status: TERMINATED ·Phase: NA
-
A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease
NCT04312659 ·Status: COMPLETED
-
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT05442567 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152 ·Status: RECRUITING ·Phase: PHASE4
-
The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease
NCT00715117 ·Status: COMPLETED ·Phase: PHASE2
-
Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients
NCT04530877 ·Status: WITHDRAWN ·Phase: PHASE4
-
Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography
NCT06107179 ·Status: RECRUITING
-
Impact of the Fecal Flora Transplantation on Crohn's Disease
NCT02097797 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease
NCT03478956 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease
NCT01548014 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin
NCT06972901 ·Status: RECRUITING ·Phase: NA